Drug interactions
Deferiprone + Exagamglogene autotemcel
Severity: Major
Deferiprone and Exagamglogene autotemcel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Iron chelators such as deferiprone can be myelosuppressive and may interfere with stem cell mobilization, conditioning and engraftment. Continuing deferiprone around these steps raises the risk of delayed hematologic recovery and infection.
What this interaction means in plain words
Deferiprone and Exagamglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Deferiprone belongs to Miscellaneous; Exagamglogene autotemcel belongs to Miscellaneous.
Why it happens
Myelosuppression from deferiprone may compromise stem cell collection and engraftment.
What to do
Discontinue deferiprone at least 7 days before mobilization and conditioning. Use a non-myelosuppressive alternative or phlebotomy if iron control is needed afterward.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Deferiprone and Exagamglogene autotemcel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Deferiprone
- Clozapine + Deferiprone Contraindicated
- Abemaciclib + Deferiprone Major
- Acalabrutinib + Deferiprone Major
- Ado-trastuzumab emtansine + Deferiprone Major
- Ado-trastuzumab + Deferiprone Major
- Aldesleukin + Deferiprone Major
Other interactions of Exagamglogene autotemcel
Frequently asked questions
Can I take Deferiprone with Exagamglogene autotemcel?
MediHelp rates the interaction as major. Deferiprone and Exagamglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Iron chelators such as deferiprone can be myelosuppressive and may interfere with stem cell mobilization, conditioning and engraftment. Continuing deferiprone around these steps raises the risk of delayed hematologic recovery and infection.
How serious is the interaction between Deferiprone and Exagamglogene autotemcel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Discontinue deferiprone at least 7 days before mobilization and conditioning. Use a non-myelosuppressive alternative or phlebotomy if iron control is needed afterward.
What other medicines interact with Deferiprone?
MediHelp also lists interactions of Deferiprone with, for example, Clozapine, Abemaciclib, Acalabrutinib. The full list is on the Deferiprone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
